Cosmax Nbt, Inc. (KOSDAQ:222040)
South Korea · Delayed Price · Currency is KRW 8,310.00
+250.00 (3.10%)
At close: Aug 24, 2026
Cosmax Nbt Market Cap
Cosmax Nbt has a market cap or net worth of 165.67 billion as of August 24, 2026. Its market cap has increased by 122.04% in one year.
Market Cap
165.67B
Enterprise Value
274.31B
Revenue
335.18B
Ranking
n/a
PE Ratio
5.94
Stock Price
8,310.00
ChartMarket Cap Chart
Since December 16, 2015, Cosmax Nbt's market cap has decreased from 299.11B to 165.67B, a decrease of -44.61%. That is a compound annual growth rate of -5.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 165.67B | 130.29% |
| Dec 30, 2025 | 71.94B | 13.45% |
| Dec 30, 2024 | 63.41B | -51.95% |
| Dec 28, 2023 | 131.96B | 49.12% |
| Dec 29, 2022 | 88.49B | -25.78% |
| Dec 30, 2021 | 119.23B | -32.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vivozon Pharmaceutical | 190.72B |
| NOVAREX | 185.44B |
| DAE HWA Pharmaceutical | 178.32B |
| CellBion | 165.06B |
| GC WellBeing | 151.01B |
| Kyung Dong Pharmaceutical | 136.06B |
| PHARMARESEARCH BIO | 131.48B |
| High Tech Pharm | 124.62B |